PQ 225
225. Deputy Thomas P. Broughan asked the Minister for Health the reason the HSE will not fund the life changing drug Respreeza which is the only proven treatment that slows the progression of emphysema caused by severe alpha-1 antitrypsin deficiency or alpha-1; and if he will make a statement on the matter. [14511/17]
Introduced
22 March 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
22 March 2017
Summary
225. Deputy Thomas P. Broughan asked the Minister for Health the reason the HSE will not fund the life changing drug Respreeza which is the only proven treatment that slows the progression of emphysema caused by severe alpha-1 antitrypsin deficiency or alpha-1; and if he will make a statement on the matter. [14511/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 22 March 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-03-22/225/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-03-22/pq_225